![Norbert Hentschel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Norbert Hentschel
Chief Executive Officer at Miltenyi Biomedicine GmbH
Profile
Norbert Hentschel is currently the Co-Managing Director at Miltenyi Biotec BV & Co. KG and the Co-Managing Director & Finance Director at Miltenyi Biomedicine GmbH.
He was previously the Co-Managing Director at Miltenyi GmbH.
Norbert Hentschel active positions
Companies | Position | Start |
---|---|---|
Miltenyi Biomedicine GmbH
![]() Miltenyi Biomedicine GmbH Pharmaceuticals: MajorHealth Technology Miltenyi Biomedicine GmbH is a German company that develops innovative cell and gene therapies with a focus on bringing cancer treatments and regenerative therapies to patients. The private company is based in Bergisch Gladbach, Germany. The CEOs are Antoon Overstijns, Stefan Miltenyi, Norbert Hentschel. The company was founded in 1989. | Chief Executive Officer | - |
Miltenyi Biotec BV & Co. KG
![]() Miltenyi Biotec BV & Co. KG BiotechnologyHealth Technology Part of Miltenyi GmbH, Miltenyi Biotec BV & Co. KG operates as a German biotech company. The company is based in Bergisch Gladbach, Germany. The CEOs are Norbert Hentschel, Stefan Miltenyi, Boris Stoffel. The company was founded in 1989. | Chief Executive Officer | - |
Former positions of Norbert Hentschel
Companies | Position | End |
---|---|---|
Miltenyi GmbH
![]() Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Chief Executive Officer | 2019-10-01 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Miltenyi GmbH
![]() Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Finance |
Miltenyi Biomedicine GmbH
![]() Miltenyi Biomedicine GmbH Pharmaceuticals: MajorHealth Technology Miltenyi Biomedicine GmbH is a German company that develops innovative cell and gene therapies with a focus on bringing cancer treatments and regenerative therapies to patients. The private company is based in Bergisch Gladbach, Germany. The CEOs are Antoon Overstijns, Stefan Miltenyi, Norbert Hentschel. The company was founded in 1989. | Health Technology |
Miltenyi Biotec BV & Co. KG
![]() Miltenyi Biotec BV & Co. KG BiotechnologyHealth Technology Part of Miltenyi GmbH, Miltenyi Biotec BV & Co. KG operates as a German biotech company. The company is based in Bergisch Gladbach, Germany. The CEOs are Norbert Hentschel, Stefan Miltenyi, Boris Stoffel. The company was founded in 1989. | Health Technology |
- Stock Market
- Insiders
- Norbert Hentschel